Correlation Between BioLineRx and Compugen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioLineRx and Compugen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLineRx and Compugen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioLineRx and Compugen, you can compare the effects of market volatilities on BioLineRx and Compugen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLineRx with a short position of Compugen. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLineRx and Compugen.

Diversification Opportunities for BioLineRx and Compugen

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between BioLineRx and Compugen is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding BioLineRx and Compugen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compugen and BioLineRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLineRx are associated (or correlated) with Compugen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compugen has no effect on the direction of BioLineRx i.e., BioLineRx and Compugen go up and down completely randomly.

Pair Corralation between BioLineRx and Compugen

Given the investment horizon of 90 days BioLineRx is expected to under-perform the Compugen. In addition to that, BioLineRx is 2.16 times more volatile than Compugen. It trades about -0.17 of its total potential returns per unit of risk. Compugen is currently generating about -0.08 per unit of volatility. If you would invest  196.00  in Compugen on September 12, 2024 and sell it today you would lose (34.00) from holding Compugen or give up 17.35% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

BioLineRx  vs.  Compugen

 Performance 
       Timeline  
BioLineRx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioLineRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Compugen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Compugen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

BioLineRx and Compugen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioLineRx and Compugen

The main advantage of trading using opposite BioLineRx and Compugen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLineRx position performs unexpectedly, Compugen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugen will offset losses from the drop in Compugen's long position.
The idea behind BioLineRx and Compugen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges